Reference and Notes
1a
Chaudhari RV.
Curr. Opin. Drug
Discovery Dev.
2008,
11:
820
1b
Breit B.
Topics
Curr. Chem.
2007,
279:
139
1c
Breit B.
Seiche W.
Synthesis
2001,
1
1d
van Leeuwen PWNM.
In Rhodium-Catalyzed Hydroformylation
Kluwer;
Dordrecht:
2000.
p.1
2
Bizzarri SN.
Fenelon S.
Ishikawa-Yamaki M.
Chemical Economics Handbook
SRI
International;
Menlo Park USA:
1999.
p.682A
Reviews:
3a
Eilbracht P.
Bärfacker L.
Buss C.
Hollmann C.
Kitsos-Rzychon BE.
Kranemann CL.
Rische T.
Roggenbuck R.
Schmidt A.
Chem. Rev.
1999,
99:
3329
3b
Eilbracht P.
Schmidt AM.
Top. Organomet. Chem.
2006,
18:
65
3c
Breit B.
Acc.
Chem. Res.
2003,
36:
264
Some selected recent examples:
4a
Vasylyev M.
Alper H.
Synthesis
2010,
2893
4b
Airiau E.
Spangenberg T.
Girard N.
Breit B.
Mann A.
Org.
Lett.
2010,
12:
528
4c
Dübon P.
Farwick A.
Helmchen G.
Synlett
2009,
1413
4d
Kemme ST.
Smejkal T.
Breit B.
Adv. Synth. Catal.
2008,
350:
989
4e
Chiou W.-H.
Mizutani N.
Ojima I.
J.
Org. Chem.
2007,
72:
1871
4f
Padwa A.
Bur SC.
Tetrahedron
2007,
63:
5341
4g
Teoh E.
Campi EM.
Jackson WR.
Robinson AJ.
Chem.
Commun.
2002,
978
4h
Hoffmann RW.
Brückner D.
Gerusz VJ.
Heterocycles
2000,
52:
121
4i
Bergmann DJ.
Campi EM.
Jackson WR.
Patti AF.
Chem.
Commun.
1999,
1279
5
Ojima I.
Tsai C.-Y.
Tzamarioudaki M.
Bonafoux D.
Org. React.
2000,
56:
1
6a
Seich W.
Schuschkowski A.
Breit B.
Adv. Synth Catal.
2005,
347:
1488
6b
Kemme ST.
Smejkal T.
Breit B.
Chem. Eur. J.
2010,
16:
3423
7a
Petricci E.
Mann A.
Rota A.
Schoenfelder A.
Taddei M.
Org. Lett.
2006,
8:
3725
7b
Petricci E.
Mann A.
Salvadori J.
Taddei M.
Tetrahedron Lett.
2007,
48:
8501
7c
Salvadori J.
Airiau E.
Girard N.
Mann A.
Taddei M.
Tetrahedron
2010,
66:
3749
7d
Airiau E.
Chemin C.
Girard N.
Lonzi G.
Mann A.
Petricci E.
Salvadori J.
Taddei M.
Synthesis
2010,
2901
8
Makado G.
Morimoto T.
Sugimoto Y.
Tsutsumi K.
Kagawa N.
Kakiuchia K.
Adv. Synth. Catal.
2010,
352:
299
Some examples of the use of formaldehydes
in hydroformylation:
9a
Smejkal T.
Han H.
Breit B.
Krische MJ.
J. Am. Chem. Soc.
2009,
131:
10366
9b
Rosales M.
Gonzalez A.
Gonzalez B.
Moratinos C.
Perez H.
Urdaneta J.
Sanchez-Delgado RA.
J. Organomet. Chem.
2005,
690:
3095
9c
Ahn HS.
Han SH.
Uhm SJ.
Seok WK.
Lee HN.
Korneeva GA.
J. Mol.
Catal. A: Chem.
1999,
144:
295
9d
Kondo T.
Akazome M.
Tsuji Y.
Watanabe W.
J. Org. Chem.
1990,
55:
1286
Degradation of formaldehyde in
carbonylation reactions:
10a
Morimoto T.
Yamasaki K.
Hirano A.
Tsutsumi K.
Kagawa N.
Kakiuchi K.
Harada Y.
Fukumoto Y.
Chatani N.
Nishioka T.
Org. Lett.
2009,
11:
1777
10b
Morimoto T.
Fujioka M.
Fuji K.
Tsutsumi K.
Kakiuchi K.
J. Organomet.
Chem.
2007,
692:
625
10c
Morimoto T.
Kiyomi K.
Angew. Chem. Int. Ed.
2004,
43:
5580
11
Airiau E.
Girard N.
Mann A.
Salvadori J.
Taddei M.
Org. Lett.
2009,
11:
5314
12 Domino hydroformylation of compounds 11-13 was described
in: Airiau E.
Spangenberg T.
Girard N.
Schoenfelder A.
Salvadori J.
Taddei M.
Mann A.
Chem. Eur. J.
2008,
14:
10938
13
(3
S
,8a
R
)-3-Phenylhexahydro-5
H
-[1,3]oxazolo[3,2-
a
]-pyridin-5-one
(20) - General Procedure
A MW vessel was
charged with [RhCl(cod)]2 (2.5 mg,
0.005 mmol), BIPHEP (5.2 mg, 0.01 mmol), and Nixantphos (5.5 mg,
0.01 mmol) under nitrogen (the reaction was carried out without
degassing the solution, an experiment done on a degassed solution,
gave comparable results). After adding toluene (3 mL), alkene 11 (103 mg, 0.5 mmol), and formalin (37%,
205 µL, 2.5 mmol), the mixture was heated for 30
min
at 90 ˚C by microwave irradiation at 250 W (value previously
settled on the microwave oven, model Discover from CEM). The solvent
was removed in vacuo and the product purified by column cromatography
(eluent hexane-EtOAc, 4:1) and isolated as a waxy material
(85 mg, 79% yield, dr > 98:2). Characterization
as in ref. 12. Compounds 24-26 were described in ref. 7d and compound 28 in ref. 5. New compounds isolated in
this work:
1-Oxaspiro[4.5]decan-2-ol
(26)
¹H NMR (400 MHz, CDCl3): δ = 5.41
(s-like, 1 H), 3.85 (br s, 1 H), 2.11-1.90 (m, 4 H), 1.58-1.40
(m, 10 H). ¹³C NMR (100 MHz, CDCl3): δ = 100.7,
89.9, 38.7, 35.5, 34.4, 32.2, 25.8, 23.7). ESI-LRMS: m/z = 179 [M + Na]+,
157 [M + H]+.
5-Hydroxy-5-(6-hydroxytetrahydro-2
H
-pyran-2-yl)-pentanal
(27)
¹H NMR (400 MHz, CDCl3): δ = 9.77
(s, 1 Ha), 9.74 (t, J = 1.6
Hz, 1 Hb), 5.48 (s, 1 Ha, 1 Hb),
4.07-4.02 (m, 2 Ha, 2 Hb), 2.54-2.50
(m, 2 Ha), 2.48-2.44 (m, 2 Hb), 1.88-1.45
(m, 10 Ha, 10 Hb). ¹³C
NMR (100 MHz, CDCl3): δ = 201.9, 102.1, 101.4,
78.8, 78.1, 43.2, 34.3, 30.5, 29.8, 28.0, 27.3, 23.9, 19.2, 17.7.
ESI-LRMS: m/z = 257 [M + MeOH + Na]+.